News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
Why Greater Seattle is a top place for innovation in health care and life sciences
Seattle-based Swedish Health Services (Swedish) completed its 500th MitraClip procedure nearly one year ago, and the 10-year program is now one of the top five
Univ. of Washington set to break ground on 69-acre redevelopment to create Seattle innovation hub
The University of Washington plans to begin construction this year on its Brightwork building as part of its Portage Bay Crossing redevelopment program. The building,
AGC Biologics to build new government-funded $350M Japanese facility
Seattle-based biotech company AGC Biologics announced that it will be adding a new preclinical and commercial manufacturing facility to its Yokohama Technical Center in Japan.
NextGen Class of 2024: Top Life Sciences Startups to Watch This Year
Seattle-based companies Bonum Therapeutics and Cajal Neuroscience are among BioSpace’s life science startups to watch in 2024. BioSpace’s NextGen Class of 2024 identified this year’s
Addiction treatment company Proniras raises $4.6M, filing shows
Proniras Corporation, a biotech company based in Seattle, raised $4.6 million in funding and is seeking nearly $8 million more, according to a recent SEC
VC investments slowed in 2023, but these Pacific Northwest startups still raised sizable rounds
Avalyn Pharma, AltPep, Viome Life Sciences and Parse Biosciences are among various Seattle startups that secured ample funding in 2023, despite tightening budgets, reduced venture
Seattle-based Neoleukin folded into New York biotech after merger
Neoleukin Therapeutics, a biotech company that spun out of the University of Washington in 2019, finalized its merger with Neurogene, a biotech firm based in
Parse Biosciences raises $50M for single cell sequencing tech
Seattle biotech startup Parse Biosciences received $50 million in funding from a Series C equity round. Capitalist firms including Soleus Capital, Marshall Wace and Bioeconomy
Prenuvo bringing its celebrity-endorsed full-body MRI scanning to new Seattle clinic in 2024
Seattle will be the site of a new Prenuvo clinic, a full-body imaging company from Silicon Valley specializing in MRI scans. The company’s full-body machine,
BMS Inks Potential $8.4B Deal for SystImmune’s ADC for Lung, Breast Cancer
Redmond-based biotech company Systimmune has secured an exclusive license and collaboration agreement with Bristol Myers Squibb (BMS) to support the development of its solid tumor
Pfizer gets OK for $43-billion Seagen deal after donating cancer drug rights
Pfizer’s pending acquisition of Seattle-based biotech company Seagen closed on December 14th, according to an announcement from Pfizer. Amid the newly approved deal, Pfizer plans
AstraZeneca will pay up to $1.1B to acquire Icosavax, a Univ. of Washington biotech spinout
AstraZeneca announced that it will pay up to $1.1 billion to acquire Seattle-based biotechnology company Icosavax. Spun out of the Institute for Protein Design at